Dr. O'Connor is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
55 Lake Ave N
Worcester, MA 01655Phone+1 508-334-3206Fax+1 774-442-4668
Education & Training
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 2013 - 2016
University of Massachusetts Medical SchoolClass of 2013
Certifications & Licensure
MA State Medical License 2016 - 2025
NH State Medical License 2013 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 141 citationsInhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor XenograftJoana M. Senra, Brian A. Telfer, Kim E Cherry, Cian M. McCrudden, David G. Hirst
Molecular Cancer Therapeutics. 2011-08-08 - 94 citationsPoly(ADP-Ribose) Polymerase-1 Inhibitor Treatment Regresses Autochthonous Brca2/p53-Mutant Mammary Tumors In vivo and Delays Tumor Relapse in Combination with CarboplatinTrevor Hay, James Matthews, Lucie Pietzka, Alan Lau, Aaron Cranston
Cancer Research. 2009-05-01 - 744 citationsHigh sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugsSven Rottenberg, Janneke E. Jaspers, Ariena Kersbergen, Eline van der Burg, Anders O.H. Nygren
Proceedings of the National Academy of Sciences of the United States of America. 2008-11-04
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
